Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) General Counsel Philip Mazzara sold 7,536 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $92.07, for a total transaction of $693,839.52. Following the sale, the general counsel now directly owns 241,209 shares in the company, valued at approximately $22,208,112.63. The trade was a 3.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
Philip Mazzara also recently made the following trade(s):
- On Thursday, February 20th, Philip Mazzara sold 50,000 shares of Astera Labs stock. The stock was sold at an average price of $87.46, for a total transaction of $4,373,000.00.
Astera Labs Price Performance
NASDAQ ALAB opened at $85.72 on Friday. The firm’s fifty day moving average price is $116.72 and its 200 day moving average price is $84.84. The company has a market capitalization of $13.90 billion and a price-to-earnings ratio of -49.55. Astera Labs, Inc. has a 12 month low of $36.22 and a 12 month high of $147.39.
Analyst Upgrades and Downgrades
ALAB has been the topic of several recent research reports. Northland Capmk raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Craig Hallum upped their target price on shares of Astera Labs from $105.00 to $125.00 and gave the stock a “buy” rating in a research note on Tuesday, February 11th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a research report on Tuesday, January 28th. Citigroup assumed coverage on shares of Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective on the stock. Finally, Morgan Stanley dropped their price objective on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $115.33.
Get Our Latest Stock Analysis on ALAB
Institutional Trading of Astera Labs
Large investors have recently bought and sold shares of the business. Whittier Trust Co. of Nevada Inc. acquired a new stake in Astera Labs during the 4th quarter worth $25,000. Hollencrest Capital Management acquired a new stake in Astera Labs during the 3rd quarter worth $26,000. Steward Partners Investment Advisory LLC boosted its stake in Astera Labs by 99.0% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC acquired a new stake in Astera Labs during the 4th quarter worth $28,000. Finally, Geneos Wealth Management Inc. acquired a new stake in Astera Labs during the 4th quarter worth $36,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Recommended Stories
- Five stocks we like better than Astera Labs
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- Conference Calls and Individual Investors
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.